文献速递神经肿瘤

松果体区胶质母细胞瘤表现出弥漫性中线与非中线胶质瘤的特征

Pineal region glioblastomas display features of diffuse midline and non-midline gliomas.
PubMed 文献 · J Neurooncol · 2018-07-10

该研究回顾了1990至2017年间在本机构手术治疗的8例松果体区胶质母细胞瘤(GBM)患者,按2016年WHO标准分类并检测组蛋白H3 K27M突变。最常见症状为头痛和视力改变(各75%),中位诊断年龄48.5岁,中位总生存期15个月。1例检出H3 K27M突变,未见IDH-1 R132H突变或1p/19q共缺失。

要点

  • 松果体区GBM罕见,本组8例中位诊断年龄48.5岁,中位总生存期15个月。
  • 头痛和视力改变各见于75%患者,步态不稳/共济失调见于50%。
  • 1例检出组蛋白H3 K27M突变,未见IDH-1 R132H突变或1p/19q共缺失。

核心结论

  • 本研究扩展了松果体区GBM的临床与病理谱系,并首次报告了这些肿瘤的遗传学特征。

研究设计与样本

  • 回顾性纳入1990至2017年间在本机构接受手术治疗的松果体区GBM患者,共8例(7男1女),按2016年WHO标准复核病理。
  • 对肿瘤组织进行组蛋白H3 K27M突变检测,并对部分病例行IDH-1 R132H突变、1p/19q共缺失检测及467个癌症相关基因的靶向外显子测序。

主要发现

  • 最常见首发症状为头痛(75%)、视力改变(75%)和步态不稳/共济失调(50%)。
  • 中位诊断年龄48.5岁(范围36-74岁),75%患者经小脑上幕下入路实现近全切除。
  • 病理复核显示7例原发GBM(含1例巨细胞GBM)和1例松果体区GBM发生于松果体实质肿瘤中间分化型切除后3年。
  • 6例检测IDH-1 R132H突变均为阴性,3例检测1p/19q共缺失均为阴性,1例组蛋白H3 K27M突变阳性。
  • 467个癌症相关基因靶向外显子测序发现ATRX和NF1无义突变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Pineal region glioblastomas (GBM) are very rare, with approximately 46 cases described in the literature. The epidemiology, pathogenesis, and treatment of these lesions are poorly characterized. METHODS: We identified all cases of pineal region GBM treated surgically at our institution between 1990 and 2017. Demographic and clinical follow-up data were extracted from the medical records for all cases. Pathology was reviewed and classified according to 2016 World Health Organization (WHO) criteria. Specific attention was given to the frequency of histone H3 K27M mutations in these midline gliomas. RESULTS: Eight patients (seven men, one woman) with pineal region GBM, WHO grade IV, were identified. The most common presenting symptoms were headache (75%), vision changes (75%), and gait imbalance/ataxia (50%). Median age at diagnosis was 48.5 years (range 36-74 years). Radical subtotal resection, via a supracerebellar infratentorial approach, was achieved in 75% of patients. Review of the surgical pathology revealed seven primary GBMs (including one giant cell GBM) and one pineal region GBM that developed three years after resection of a pineal parenchymal tumor of intermediate differentiation. No cases demonstrated evidence of IDH-1 R132H mutation (N = 6) or 1p/19q co-deletion (N = 3). One case tested positive for the histone H3 K27M-mutation. Targeted exome sequencing of 467 cancer-related genes revealed nonsense mutations in ATRX and NF1. Adjuvant radiation and chemotherapy was employed in 87.5% and 75.0% of patients, respectively. Median overall survival (OS) was 15 months (range 2-24 months) from GBM diagnosis. CONCLUSIONS: This study expands the clinical and pathologic spectrum of pineal region GBM, and provides the first report of the genetic landscape of these tumors.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. D'Amico RS, Zanazzi G, Wu P, et al. Pineal region glioblastomas display features of diffuse midline and non-midline gliomas. J Neurooncol. 2018. PMID: 29992434. doi:10.1007/s11060-018-2931-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。